References
- Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 2009;201:445.e1–13.
- Clark SL. Amniotic fluid embolism. Obstet Gynecol 2014;123:337–48.
- Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol 2016;215:408–12.
- Knight M, Berg C, Brocklehurst P, et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregn Childbirth 2012;12:7.
- Fitzpatrick K, Tuffnell D, Kurinczuk J, et al. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG 2015;123:100–9.
- Indraccolo U, Ventrone R, Scutiero G, et al. Interventions for treating amniotic fluid embolism: a systematic review with meta-analysis. Clin Exp Obstet Gynecol. 2017. [Epub ahead of print]. (in press).
- Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol 2012;2012:946576.
- Tuffnell DJ, Slemeck E. Amniotic fluid embolism. Obstet Gynaecol Reprod Med 2014;24:148–52.
- Shen F, Wang L, Yang W, et al. From appearance to essence: 10 years review of atypical amniotic fluid embolism. Arch Gynecol Obstet 2016;293:329–34.
- Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995;172:1158–67.
- Offerhaus PM, de Jonge A, van der Pal-de-Bruin KM, et al. Change in primary midwife-led care in the Netherlands in 2000–2008: a descriptive study of caesarean sections and other interventions among 807,437 low-risk births. Midwifery 2015;31:648–54.
- Birthplace in England Collaborative Group, Brocklehurst P, Hardy P, et al. Perinatal and maternal outcomes by planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national prospective cohort study. BMJ 2011;343:d7400.
- Selin L, Almström E, Wallin G, et al. Use and abuse of oxytocin for augmentation of labor. Acta Obstet Gynecol Scand 2009;88:1352–7.
- Rossen J, Østborg TB, Lindtjørn E, et al. Judicious use of oxytocin augmentation for the management of prolonged labor. Acta Obstet Gynecol Scand 2016;95:355–61.
- Oi H, Naruse K, Koike N, et al. Predictor of mortality in patients with amniotic fluid embolism. J Obstet Gynaecol Res 2014;40:941–5.
- Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res 2014;40:1507–17.
- McDonnell N, Knight M, Peek MJ, et al. Amniotic fluid embolism: an Australian-New Zealand population-based study. BMC Pregnancy Childbirth 2015;15:352.
- Maternal health study group of the Canadian Perinatal Surveillance System. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006;368:1444–8.
- Rosseland LA, Hauge TH, Grindheim G, et al. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology 2013;119:541–51.
- Svanström MC, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth 2008;100:683–9.